关税又有变数，白宫最新发声！贵金属深夜拉涨，白银创14年新高，年内涨幅达59%

Group 1: US Tariff Policy Changes - The latest US tariff measures on pharmaceuticals will not apply to countries that have trade agreements with the US, such as the EU and Japan, which will continue to adhere to the agreed 15% tariff cap [2][5] - The UK, however, will face a 100% tariff on pharmaceutical exports to the US, as negotiations on drug-related tax rates are still ongoing [5] Group 2: Market Reactions and Economic Data - Following the announcement of the tariff changes, the Asia-Pacific pharmaceutical stocks experienced declines, with companies like BeiGene down 4% and Sumitomo Pharma down over 3% [2] - On September 26, US stock indices saw gains, with the Dow Jones up 0.65% and the S&P 500 up 0.59%, driven by inflation data that raised expectations for interest rate cuts [6][12] - The Michigan Consumer Sentiment Index for September was reported at 55.1, slightly lower than the preliminary value, while the core PCE price index showed a year-on-year increase of 2.9%, aligning with market expectations [13] Group 3: Precious Metals Market - The precious metals market experienced a significant rally, with COMEX gold futures rising 0.5% to $3789.8 per ounce and silver futures up 2.77% to $46.365 per ounce, marking a 14-year high for silver [15][16] - Over the past six months, silver has seen a cumulative increase of over 30%, outperforming most commodities, with a year-to-date rise of 59%, compared to gold's 43% [17] - The current gold-silver ratio indicates that silver is undervalued relative to historical averages, suggesting potential for price correction [18]